Quantcast
Last updated on April 18, 2014 at 9:00 EDT

Latest D-dimer Stories

2013-08-07 10:13:29

The D-dimer test is often used to rule out the presence of venous thromboembolism; however, the test has been considered unreliable in postoperative patients because D-dimer levels may rise after surgery. Researchers from the Department of Neurosurgery at the University of Halle in Germany hypothesized that this rise might be systematic and predictable, in which case a feasible postoperative threshold of D-dimer indicating venous thromboembolism could be determined. The results of this study...

2013-07-23 08:31:28

-- Augments Fully Automated Assay Menu for the Detection of Fibrinolytic Disorders -- BEDFORD, Mass., July 23, 2013 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced the release of the HemosIL FDP assay as a European CE IVD Mark product under the European Directive on in vitro Diagnostic Medical Devices. The assay will be commercialized in countries throughout Europe, Asia, and other international markets. FDP is an immunoturbidimetric assay designed for the detection...

2010-11-07 10:45:36

Kaiser Permanente study outlines health care IT best practice An electronic message sent to physicians the moment they ordered a blood test for elderly patients reduced unnecessary use of the test that is often false-positive for the elderly, according to a paper published in the November edition of American Journal of Managed Care. The D-dimer test, combined with a clinical risking algorithm, can help in the diagnosis of deep vein thrombosis (blood clots in veins, otherwise known as DVTs)...

2010-09-09 11:13:00

WASHINGTON, Sept. 9 /PRNewswire-USNewswire/ -- For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, according to a recent study published today in Blood, the journal of the American Society of Hematology. VTE, the formation of blood clots in the veins, develops in up to 20 percent of cancer patients and is one of the...

2010-06-15 15:27:04

A new study suggests that computed tomography (CT) angiography might be unnecessary in many patients suspected of having pulmonary embolism (PE), based on the results of risk assessment analysis. PE risk assessment could help reduce radiation exposure and costs associated with CT angiography. The results of the study appear in the online edition and August print issue of the journal Radiology. "Our study suggests that the frequency of ordering CT angiograms can be markedly reduced with...

2010-02-23 07:30:00

BEDFORD, Mass., Feb. 23 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its HemosIL D-Dimer HS 500 assay. Additionally, the Company received a license from Health Canada for the product. The Company will now initiate commercialization of HemosIL D-Dimer HS 500 in North America, with their distribution partner, Beckman Coulter, Inc. In April 2009, the assay was previously released in...

2010-02-03 12:38:14

An analysis of previous studies suggests that for patients with a suspected blood clot in a deep vein of a leg, withholding anticoagulation therapy after a negative whole-leg compression ultrasound is associated with a low risk of developing a blood clot during the subsequent 3 months, suggesting that multiple ultrasounds may not be necessary for some low-risk patients, according to an article in the February 3 issue of JAMA. Compression ultrasound (CUS) is the primary testing procedure used...

2009-06-24 08:38:00

CORTLANDT MANOR, N.Y., June 24 /PRNewswire/ -- Polymedco, Inc. is pleased to announce the introduction of the PATHFAST immunoassay analyzer, manufactured by Mitsubishi Chemical Medience Corporation, Tokyo, Japan. The PATHFAST rapid point of care system utilizes a chemiluminescent technology combined with a unique separation method using magnetic particles that allows this system to report highly accurate results that compare to large platform instruments. The PATHFAST system employs...

2009-05-25 22:48:58

Emergency room physicians may not be following clinical guidelines for diagnosing patients with possible lung blood clots, U.S. researchers say. Researchers at the Warren Alpert Medical School of Brown University and Rhode Island Hospital in Providence, R.I., said current accepted clinical practice indicates patients with a low clinical suspicion for pulmonary emboli should undergo a blood test for D-dimer, a protein fragment present in the blood after a clot is degraded, then multi-detector...

2008-08-29 12:01:17

Instrumentation Laboratory, a developer of in vitro diagnostic instruments, has announced that the FDA has granted 510(k) clearance to expand the intended use for the HemosIL D-dimer assay to exclude venous thromboembolism in outpatients suspected of deep venous thrombosis and pulmonary embolism, when used in conjunction with a clinical pretest probability assessment model. As a part of the 510(k), Instrumentation Laboratory (IL) performed a multi-center clinical study involving more than...